Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher's science and technology leadership puts Cepheid's solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher's other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
市場タイムラインとシグナルフィードを解放
新しいマーケティング・PRのアクティビティ — 8 件の新規シグナルが出現しました。
この企業が各市場へ参入した順序 — 古い順から新しい順へ
Field Applications Engineer - Molecular Diagnostics (IVD)
10 active postings
登録してシグナルフィードをすべて表示
Cepheid の海外展開を競合と比較
Cepheid自社バーは比較対象企業間の相対的な規模を示します。
列5| 企業 | 市場 | 新規市場 | モメンタム | アクティビティ | 拡大スコア |
|---|---|---|---|---|---|
 Cepheid自社 | 9 | 3 | +1200% | 14 | 30 |
Lead Biostatistician, Global Quality, Regulatory, Clinical Affairs
求人を見るBengaluru East, Karnataka, India · 先週
Lead Computer Integration Engineer
求人を見るPenang, Penang, Malaysia · 3週間前
Supplier Development & CM Transfer Engineer
求人を見るPenang, Penang, Malaysia · 3週間前
☝️ What if every treatment decision started with better diagnostics?🎤 In this Cepheid Talks podcast episode, Dr. Ephraim Tsalik shares his perspective on the evolving role of diagnostics in clinical decision-making and antimicrobial resistance (AMR). 💫 From advancing innovation to enabling more precise, timely care, this conversation explores how diagnostics can help shape better outcomes for both clinicians and patients.Tune in now: https://ow.ly/44zi50Z7oxA ...
実施中
C. difficile Is Not Just Another GI Pathogen — Why Testing Strategy MattersHigh rates of asymptomatic colonization mean that how we test for C. difficile directly impacts diagnosis, treatment decisions, antimicrobial exposure, and stewardship outcomes.🎥 Now available on demand:Watch our global expert webinar to explore:• Colonization vs. true infection• The clinical impact of testing strategy• Diagnostic & antimicrobial stewardship• Practical insights for clinicians and labs👉 Access the on‑dem ...
終了Hi %FIRSTNAME%At ESCMID Global 2026, experts explored how diagnostic stewardship, smart molecular panels, and the evolving role of metagenomics are shaping more confident clinical decision‑makingIf you couldn’t attend in Munich, you haven’t missed your opportunity. Catch up on the topics belowAccess the recorded symposium and catch up on your own schedule.
終了認証済みメールと直通電話を解放
無料 · カード不要
Cepheid の事業、市場、成長シグナルに関する簡潔な回答。
© 2026 Pubrio. 無断転載を禁じます。
